Clobetasol propionate 0.5 MG/ML Topical Solution — RxCUI 861487
RxNorm drug concept · Semantic clinical drug
RxCUI 861487
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
20 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861487
Official nameClobetasol propionate 0.5 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclobetasol propionate 0.05 % Topical Solution
FDA products mapped12
Package NDCs mapped20
Reported Medicaid activity (SDUD)244,916 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clobetasol Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes — clobetasol is classified as a super-high potency steroid, which puts it in the strongest category of topical corticosteroids available. It's used for stubborn inflammatory sk...
- What is clobetasol used for, and is it really that much stronger than other steroid creams?
- Apply it to a dry scalp — not wet hair — in a thin film over the affected areas only. Leave it on for 15 minutes, then add water, lather, and rinse everything thoroughly, including...
- How do I use the shampoo version correctly?
🕸️ Concept Web — How Clobetasol propionate 0.5 MG/ML Topical Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clobetasol propionate 0.5 MG/ML Topical Solution
RxCUI 861487 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Clobetasol
2590IN -
Clobetasol propionate
21245PIN
-
Clobetasol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clobetasol Topical Solution
544933SCDF -
Clobetasol propionate Topical Solution
2646875SCDFP -
Clobetasol Topical Product
1153083SCDG -
Clobetasol propionate Topical Product
2659863SCDGP -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Clobetasol Topical Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clobetasol propionate 0.5 MG/ML
861352SCDC
-
Clobetasol propionate 0.5 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clobetasol propionate 0.5 MG/ML
SCDC · 861352 -
Clobetasol Topical Solution
SCDF · 544933 -
Clobetasol propionate Topical Solution
SCDFP · 2646875 -
Clobetasol Topical Product
SCDG · 1153083 -
Clobetasol propionate Topical Product
SCDGP · 2659863
📦 FDA Products & Package NDCs
12 products · 20 package NDCs
20 package NDCs map to RxCUI 861487 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00168-0269-50 | 50 mL in 1 BOTTLE, PLASTIC (0168-0269-50) | Clobetasol Propionate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1999-02-08 |
| 21922-0061-22 | 1 BOTTLE in 1 CARTON (21922-061-22) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Encube Ethicals, Inc. | 2024-06-10 |
| 21922-0061-27 | 1 BOTTLE in 1 CARTON (21922-061-27) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Encube Ethicals, Inc. | 2024-06-10 |
| 40032-0028-60 | 1 BOTTLE in 1 CARTON (40032-028-60) / 50 mL in 1 BOTTLE | clobetasol propionate | Novel Laboratories, Inc. | 2015-11-23 |
| 42571-0362-81 | 1 BOTTLE in 1 CARTON (42571-362-81) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Micro Labs Limited | 2019-10-02 |
| 42571-0362-99 | 1 BOTTLE in 1 CARTON (42571-362-99) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Micro Labs Limited | 2019-10-02 |
| 43386-0028-60 | 1 BOTTLE in 1 CARTON (43386-028-60) / 50 mL in 1 BOTTLE | clobetasol propionate | Lupin Pharmaceuticals,Inc. | 2015-11-23 |
| 46708-0486-25 | 1 BOTTLE in 1 CARTON (46708-486-25) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | 2025-03-17 |
| 46708-0486-50 | 1 BOTTLE in 1 CARTON (46708-486-50) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | 2025-03-17 |
| 50090-5264-00 | 1 BOTTLE in 1 CARTON (50090-5264-0) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | A-S Medication Solutions | 2020-10-16 |
| 51407-0737-25 | 1 BOTTLE in 1 CARTON (51407-737-25) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Golden State Medical Supply, Inc. | 2023-08-29 |
| 51407-0737-50 | 1 BOTTLE in 1 CARTON (51407-737-50) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Golden State Medical Supply, Inc. | 2023-08-29 |
| 51672-1293-02 | 1 BOTTLE, PLASTIC in 1 CARTON (51672-1293-2) / 25 mL in 1 B... | Clobetasol Propionate | Sun Pharmaceutical Industries, Inc. | 1998-11-16 |
| 51672-1293-03 | 1 BOTTLE, PLASTIC in 1 CARTON (51672-1293-3) / 50 mL in 1 B... | Clobetasol Propionate | Sun Pharmaceutical Industries, Inc. | 1998-11-16 |
| 62332-0486-25 | 1 BOTTLE in 1 CARTON (62332-486-25) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Inc. | 2019-10-24 |
| 62332-0486-50 | 1 BOTTLE in 1 CARTON (62332-486-50) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Inc. | 2019-10-24 |
| 68462-0532-28 | 1 BOTTLE in 1 CARTON (68462-532-28) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Glenmark Pharmaceuticals Inc., USA | 2018-04-18 |
| 68462-0532-53 | 1 BOTTLE in 1 CARTON (68462-532-53) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Glenmark Pharmaceuticals Inc., USA | 2018-04-18 |
| 70752-0153-04 | 1 BOTTLE in 1 CARTON (70752-153-04) / 50 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Quagen Pharmaceuticals LLC | 2022-03-14 |
| 70752-0153-20 | 1 BOTTLE in 1 CARTON (70752-153-20) / 25 mL in 1 BOTTLE | CLOBETASOL PROPIONATE | Quagen Pharmaceuticals LLC | 2022-03-14 |
Observed labelers:
Alembic Pharmaceuticals Inc. (2) ·
Alembic Pharmaceuticals Limited (2) ·
Encube Ethicals, Inc. (2) ·
Glenmark Pharmaceuticals Inc., USA (2) ·
Golden State Medical Supply, Inc. (2) ·
Micro Labs Limited (2)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1188
Range $0.1172–$0.2504
· middle 50% $0.1172–$0.2504
· 12 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.